Lubomir Sokol
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 66
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 25
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 131
- Dermatology top 0.5%
- Cutaneous lymphoproliferative disorders research 54
- Oncology top 1%
- CAR-T cell therapy research 38
- Viral-associated cancers and disorders 37
-
- T-cell and Retrovirus Studies 29
-
- CNS Lymphoma Diagnosis and Treatment 22
- Co-authors
- Samir DaliaThomas P. LoughranAlan F. ListLauren Pinter‐BrownJulio C. ChávezBarbara ProFrancine M. FossElizabeth M. Sagatys
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (2 papers)Journal of Clinical Oncology (18 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Lubomir Sokol
250 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 1.4k
- Hematology 1.3k
- Pathology and Forensic Medicine 2.0k
- Dermatology 823
- Oncology 1.8k
Countries citing papers authored by Lubomir Sokol
This map shows the geographic impact of Lubomir Sokol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubomir Sokol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubomir Sokol more than expected).
Fields of papers citing papers by Lubomir Sokol
This network shows the impact of papers produced by Lubomir Sokol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubomir Sokol. The network helps show where Lubomir Sokol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lubomir Sokol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 4 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 0 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 6 | |
| 12 | 2018 | 24 | |
| 13 | 2016 | 9 | |
| 14 | 2015 | 12 | |
| 15 | 2014 | 2 | |
| 16 | 2013 | 166 | |
| 17 | 2013 | 18 | |
| 18 | Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapybreakdown → | 2012 | 485 |
| 19 | 2010 | 3 | |
| 20 | 2004 | 20 |
About Lubomir Sokol
Lubomir Sokol is a scholar working on Genetics, Pathology and Forensic Medicine and Dermatology, having authored 269 papers that have together received 5.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (131 papers), Chronic Lymphocytic Leukemia Research (66 papers), Cutaneous lymphoproliferative disorders research (54 papers), CAR-T cell therapy research (38 papers), Viral-associated cancers and disorders (37 papers), T-cell and Retrovirus Studies (29 papers), Acute Myeloid Leukemia Research (25 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). The work is most often cited by research in Genetics (1.4k citations), Hematology (1.3k citations) and Pathology and Forensic Medicine (2.0k citations). Lubomir Sokol has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Samir Dalia, Thomas P. Loughran, Alan F. List, Lauren Pinter‐Brown, Julio C. Chávez, Barbara Pro, Francine M. Foss, Elizabeth M. Sagatys, Bertrand Coiffier and Sarah McCue Horwitz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.